Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Equity Ratio (2018 - 2026)

Bicycle Therapeutics (BCYC) has disclosed Equity Ratio for 9 consecutive years, with 0.85 as the latest value for Q1 2026.

  • For Q1 2026, Equity Ratio rose 1.44% year-over-year to 0.85; the TTM value through Mar 2026 reached 0.85, up 1.44%, while the annual FY2025 figure was 0.85, 2.56% up from the prior year.
  • Equity Ratio hit 0.85 in Q1 2026 for Bicycle Therapeutics, roughly flat from 0.85 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.85 in Q4 2025 and bottomed at 0.48 in Q2 2023.
  • Average Equity Ratio over 5 years is 0.73, with a median of 0.72 recorded in 2022.
  • Year-over-year, Equity Ratio plummeted 30.67% in 2023 and then soared 70.53% in 2024.
  • Bicycle Therapeutics' Equity Ratio stood at 0.66 in 2022, then decreased by 5.52% to 0.62 in 2023, then soared by 33.02% to 0.83 in 2024, then increased by 2.56% to 0.85 in 2025, then dropped by 0.04% to 0.85 in 2026.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.85, 0.85, and 0.81 for Q1 2026, Q4 2025, and Q3 2025 respectively.